Coherus BioSciences Announces New Employment Inducement Grants
Coherus BioSciences announced the grant of stock options on February 1, 2023, to three new employees, totaling 22,500 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Coherus BioSciences announced the grant of stock options on February 1, 2023, to three new employees, totaling 22,500 shares. The exercise price for these options is set at $8.65, equal to the closing stock price on the grant date. This initiative is part of the 2016 Employment Commencement Incentive Plan, designed to attract and retain talent within the company. The plan was approved under Nasdaq regulations, emphasizing Coherus's commitment to strengthening its workforce and enhancing operational capacity.
Positive
- Grant of 22,500 stock options to attract new talent.
- Exercise price of $8.65 aligns with the market, promoting confidence.
Negative
- None.
Details
News Market Reaction – CHRS
The recorded move for CHRS in the trading session of this news was -1.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective February 1, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 22,500 shares of the common stock of the Company to three newly hired employees with a per share exercise price of
The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.
Coherus BioSciences Contact Information:
IR Contact
Marek Ciszewski
Coherus BioSciences, Inc.
IR@coherus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.